PubMed · 12992867
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
A SCHURCH. 1952. [The chromium oxide indicator method to determine digestability].. https://pubmed.ncbi.nlm.nih.gov/12992867/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
A pilot-scale treatment study was implemented at a deposition site of chromite ore processing residue (COPR) in New Jersey. Ferrous sulfate heptahydrate (FeSO4 x 7H2O) was employed to reduce hexavalent chromium in two dosages with three types of soil mixing equipment. XANES analyses of treated samples cured for 240 days indicated that all treatment combinations failed to meet the Cr(VI) regulatory limit of 240 mg/kg. More importantly, the discrepancy between XANES and alkaline digestion results renders the latter unreliable for regulatory purposes when applied to ferrous-treated COPR. Regardless of Cr-(VI), the introduction of reductant containing sulfate, mechanical mixing, water, acidity, and the resulting temperature increase in treated COPR promoted dissolution of brownmillerite (Ca2FeAlO5), releasing alumina and alkalinity. The pH increase caused initially precipitated gypsum (CaSO4 x 2H2O) to progressively convert to ettringite (Ca6Al2(SO4)3 x 32H2O) and its associated volume expansion under both in situ and ex situ conditions, with a maximum of 0.8 m vertical swell within 40 days of curing. While Cr-(VI) treatment remains a challenge, the intentional exhaustion of the heave potential of COPR by transforming all Al sources to ettringite emerges as a possible solution to delayed ettringite formation, which would hamper site redevelopment.
The Cr(V) complexes, bis(2-ethyl-2-hydroxybutyrato)oxochromate(V) ([OCr(V)(ehba)(2)](-)) and (2,2-bis(hydroxymethyl)-2-(bis(2-hydroxyethyl)amino)ethanolato)oxochromate(V) ([OCr(V)(BT)](2-)), were reacted with a series of deoxyribonucleotide triphosphates. Oxidation of deoxyribose at C4' was observed by measuring the amount of thiobarbituric acid reactive species (TBARS) produced in these reactions. For both compounds, the TBARS obtained with purine nucleotides was between 2.25 and 3.5 times greater than what was observed with pyrimidine nucleotide. This result suggests that the identity of the nucleic acid base can influence the hydrogen atom abstraction at C4'. Overall, the amount of product obtained with [OCr(V)(BT)](2-) was significantly less than what was observed with [OCr(V)(ehba)(2)](-), indicating that these two Cr(V) model complexes may oxidize DNA differently.
The reaction of [Cr(urea)(6)]Cl(3).3H(2)O with H(2)salen (H(2)salen=N,N(')-ethylenebis(salicylaldimine) in water-methanol mixture (40:60v/v) under reflux yielded the complex bis[N-(2-aminoethyl)salicylaldiminato]chromium(III) chloride monohydrate, [Cr(aesaldmn)(2)]Cl.H(2)O. The complex was characterized by elemental analysis, molar conductance, magnetic susceptibility, spectroscopic (UV-vis and IR) data and X-ray diffraction studies. The new ligand, N-(2-aminoethyl)salicylaldimine, Haesaldmn, possibly resulted from the hydrolytic cleavage of one end of the H(2)salen ligand during reflux. Binding of this chromium(III) complex to CT DNA has been studied using UV-vis spectroscopy with an apparent binding constant of 2.68 x 10(3)M(-1). It shows that the binding mode is electrostatic while the emission of ethidium bromide to CT DNA in the absence and in the presence of the complex show that it binds DNA with partial intercalation.